On Wednesday, November 18, Anthropic, the San Francisco company that makes the Claude AI models, set the price for its first sale of stock to the public, called an initial public offering, or IPO. It sold 980 million shares at $83 each, above the $70 to $78 range it suggested last week. That adds up to about $81.3 billion, which CNBC calls the largest IPO on record, topping SpaceX’s sale in June. (SpaceX’s total later grew to $85.7 billion when its bankers bought extra shares, and Anthropic’s bankers have a similar option to buy up to 147 million more.) Counting every share, Anthropic is now valued at about $1.5 trillion.

Shares are set to start trading today on the Nasdaq stock exchange under the ticker symbol “ANT,” and CEO Dario Amodei and his fellow co-founders are scheduled to ring the bell that opens the market, The Guardian reports. Amodei and a small group of researchers left OpenAI to start Anthropic in 2021. This year its growth has been explosive, driven largely by Claude Code, its AI coding tool: revenue for the first nine months of 2026 was $33.24 billion, up about 1,200% from the same stretch last year, according to its filing.

It is also spending enormous sums. Anthropic reported a $104 billion net loss for those nine months, though CNBC notes that most of it came from an accounting charge tied to some of its earlier funding deals, not from day-to-day costs. Its biggest bill is computing power: it has committed to more than $70 billion for data centers over the next 12 months and more than $450 billion by 2030, The Guardian reports. Big tech is deeply tied in. Amazon and Google each own stakes worth more than $100 billion, and Google, Microsoft, Nvidia, and AMD agreed to buy a combined $26 billion of shares at the IPO price.

The timing is tense. CNBC calls the listing a major test for AI after a rough stretch, including last week’s exit of Nvidia CEO Jensen Huang and a voter backlash against AI in the midterm elections. Anthropic’s filing lists more than 90 pages of risks. Rival OpenAI has confidentially filed to go public and has said its debut is likely in 2027. “I think if we do this right, we can create an age of miracles,” Amodei said in a video for investors, adding that the company has to “very carefully address” the ways the technology can go wrong.